Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Beata Kumiega"'
Autor:
Andrzej Budzyński, Sergiusz Demczuk, Beata Kumiega, Marcin Migaczewski, Maciej Matłok, Anna Zub-Pokrowiecka
Publikováno v:
Videosurgery and Other Miniinvasive Techniques, Vol 6, Iss 4, Pp 249-255 (2011)
The authors describe a case of sclerosing angiomatoid nodular transformation (SANT) of the spleen treated at the 2ndDepartment of Surgery, Jagiellonian University, Medical College. The patient was a 23-year-old woman. Clinically shepresented with 2-y
Externí odkaz:
https://doaj.org/article/ede9d09233894e0fb3c4a5737d2174db
Autor:
Anna Waszczuk-Gajda, Anna Kulikowska de Nalecz, Marta Sobas, Krzysztof Zduniak, Monika Joks, Edyta Subocz, Tomasz Wróbel, Laura Bao Perez, Małgorzata Gajewska, Joanna Drozd-Sokołowska, Anna Czyż, Beata Kumiega, Kamel Laribi, Joanna Romejko-Jarosinska, Magdalena Olszewska-Szopa
Publikováno v:
Acta Oncologica. 60:1361-1368
Introduction: Primary cutaneous indolent B-cell lymphomas (PCBCLs) are not well characterized due to their rarity and indolent character.Methods: We retrospectively reviewed the data from 52 patients with primary cutaneous follicular lymphoma (PCFL)
Autor:
Marek Dudziński, Monika Długosz-Danecka, Małgorzata Wojciechowska, Michal Osowiecki, Elżbieta Iskierka-Jażdżewska, Weronika Piszczek, Jan Maciej Zaucha, Agnieszka Szymczyk, Edyta Subocz, Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Beata Kumiega, Krzysztof Giannopoulos, Ryszard Wichary, Marek Hus, Bartosz Pula, Wojciech Jurczak, Tadeusz Robak, Bożena Katarzyna Budziszewska, Janusz Hałka, Wanda Knopinska-Posluszny, Krzysztof Jamroziak, Agnieszka Szeremet, Andrzej Pluta, Daria Zawirska, Paweł Steckiewicz, Jadwiga Hołojda, Ewa Lech-Marańda
Publikováno v:
Anticancer Research. 40:4059-4066
Background/aim To study the long-term clinical efficacy and tolerability of ibrutinib monotherapy in real-world relapsed and refractory chronic lymphocytic leukemia (RR-CLL) patients outside clinical trials. Patients and methods Clinical data of 171
Autor:
Beata Kumiega, Katarzyna Kobylińska, Agnieszka Giza, Monika Długosz-Danecka, Wojciech Spychałowicz, Joanna Drozd-Sokołowska, Wanda Knopinska-Posluszny, Sebastian Giebel, Wieslaw Wiktor-Jedrzejczak, Joanna Fischer, Przemyslaw Biecek, Tomasz Wróbel, Jan Maciej Zaucha, Joanna Romejko-Jarosinska, Wojciech Jurczak, Monika Joks
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Comorbidities impair the prognosis of diffuse large B-cell lymphoma (DLBCL). Type 2 diabetes mellitus (DMT2) increases the risk of other comorbidities, e.g., heart failure (HF). Thus, we hypothesized that pre-existing DMT2 may negatively affect the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d27f2a7cadef15497a99d4bb3bbaefbd
https://ruj.uj.edu.pl/xmlui/handle/item/257436
https://ruj.uj.edu.pl/xmlui/handle/item/257436
Autor:
Małgorzata Wojciechowska, Marek Dudziński, Waldemar Kulikowski, Edyta Subocz, Magdalena Piotrowska, Janusz Hałka, Andrzej Pluta, Wanda Knopinska-Posluszny, Elżbieta Iskierka-Jażdżewska, Weronika Piszczek, Beata Kumiega, Jadwiga Hołojda, Krzysztof Jamroziak, Krzysztof Warzocha, Daria Zawirska, Aleksandra Gołos, Anna Waszczuk-Gajda, Paweł Steckiewicz, Krzysztof Giannopoulos, Marcin Pasiarski, Miroslaw Markiewicz, Michal Osowiecki, Dominik Chraniuk, Jan Maciej Zaucha, Agnieszka Szymczyk, Joanna Drozd-Sokołowska, Bartosz Pula, Marek Hus, Tadeusz Robak, Agnieszka Szeremet
Publikováno v:
Acta Haematologica Polonica. 48:330-337
Background The 17p deletion is regarded as the strongest poor prognostic factor in chronic lymphocytic leukemia (CLL). Results of recently performed clinical trials have suggested that ibrutinib significantly improves the outcome in this patient grou
Autor:
Ewa Kalinka-Warzocha, Krzysztof Adamowicz, Joanna Drozd-Sokołowska, Wojciech Spychałowicz, Beata Kumiega, Edyta Subocz, Natalia Sorbotten, Przemyslaw Biecek, Justyna Rybka, Ewa Chmielowska, Agata Tyczyńska, Maciej Machaczka, Andrzej Balcerzak, Agata Salek, Agnieszka Badora-Rybicka, Tomasz Wróbel, Krzysztof Leśniewski-Kmak, Anna Szulgo, Wojciech Jurczak, Jan Maciej Zaucha, R. Kroll-Balcerzak, Wanda Knopinska-Posluszny, Jadwiga Hołojda, Joanna Pogrzeba, Waldemar Kulikowski, Olga Dobrzyńska, Agnieszka Giza, Elżbieta Nowara
We retrospectively analyzed long-term disease outcome of 350 elderly Hodgkin Lymphoma (eHL) patients treated with ABVD/ABVD-like regimen enrolled in the PLRG-R9 study between 2001 and 2013 in Poland. Complete remission was reported for 73% of early (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::938a85b6e262cfbc390c8f4e9804d634
https://ruj.uj.edu.pl/xmlui/handle/item/143752
https://ruj.uj.edu.pl/xmlui/handle/item/143752
Autor:
Janusz Hałka, Elżbieta Iskierka-Jażdżewska, Weronika Piszczek, Krzysztof Warzocha, Marek Hus, Magdalena Piotrowska, Tadeusz Robak, Beata Kumiega, Krzysztof Jamroziak, Elżbieta Mądro, Wanda Knopinska-Posluszny, Jan Maciej Zaucha, Paweł Steckiewicz, Paulina Wieszczy, Krzysztof Giannopoulos, Agnieszka Szeremet, Jadwiga Hołojda, Joanna Drozd-Sokołowska, Marek Dudziński, Marek Osowiecki, Slawomira Kyrcz-Krzemien, Małgorzata Wojciechowska
Publikováno v:
Leukemialymphoma. 58(10)
It is widely understood that outcomes of specific therapy and the burden of adverse events (AEs) found in clinical trials may differ from those seen in routine clinical practice. Several clinical t...
Autor:
Grzegorz Charliński, Wanda Knopinska-Posluszny, Grzegorz Słomian, Monika Długosz-Danecka, Wojciech Jurczak, Sebastian Szmit, Jan Maciej Zaucha, Joanna Drozd-Sokołowska, Beata Kumiega, Marta Morawska, Barbara Sosnowska-Pasiarska, Monika Joks, Ewa Chmielowska, Wojciech Spychałowicz
Background Algorithm of anthracycline-based chemotherapy with favourable cardio-oncological outcome should be clearly re-defined for lymphoma patients with significant pre-existing cardiovascular diseases. A clinical benefit of liposomal forms of ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f5efaaf78a216346ec08bed5c7740a
https://ruj.uj.edu.pl/xmlui/handle/item/96103
https://ruj.uj.edu.pl/xmlui/handle/item/96103
Autor:
Aleksandra Butrym, Joanna Drozd-Sokołowska, Beata Kumiega, Agnieszka Giza, Ewa Paszkiewicz-Kozik, Tomasz Wróbel, Wojciech Jurczak, Kazimierz Kuliczkowski, Justyna Rybka
Background The treatment of patients with relapsed or refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) remains challenging. Gemcitabine is a cytidine analog with a wide spectrum of antitumor activity. Gemcitabine treatment is widely us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd7cc620a1fb3cf5cdb3c6582fd7aa4
https://ruj.uj.edu.pl/xmlui/handle/item/102317
https://ruj.uj.edu.pl/xmlui/handle/item/102317
Autor:
Beata, Kumiega, Wojciech, Jurczak, Szymon, Fornagiel, Justyna, Dzietczenia, Aleksander B, Skotnicki
Publikováno v:
Przeglad lekarski. 70(4)
The involvement of central nervous system in the course of lymphoma is an adverse prognostic factor, therefore primary prevention is a standard of care of aggressive lymphoma subtypes. The aim of the paper is the safety and efficiency, retrospective